Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19) - protocol of randomised controlled trial AZIQUINE-ICU

František Duška, Petr Waldauf, Milada Halačová, Václav Zvoníček, Jakub Bala, Martin Balík, Jan Beneš, Olga Klementová, Irena Kozáková, Viktor Kubricht, Anne Le Roy, Tomáš Vymazal, Veronika Řehořová, Vladimír Černý

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
Original languageEnglish
Article numbers13063
JournalTrials
Volume21
Issue number1
DOIs
Publication statusPublished - Jul 8 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology (medical)
  • Medicine (miscellaneous)

Keywords

  • Azithromycin
  • COVID-19
  • Hydroxychloroquine
  • Novel coronavirus
  • Respiratory failure
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19) - protocol of randomised controlled trial AZIQUINE-ICU'. Together they form a unique fingerprint.

Cite this